This proposal is the first competitive renewal of the Mental Health Clinical Research Center (MHCRC) since 1988, when there was a change in Center leadership. The Center has now focused its efforts on further characterizing the brain dysmorphology of schizophrenia and understanding its functional significance. To broaden this characterization we will study other psychiatric and neurological patient groups, sharing putative behavioral or structural abnormalities with schizophrenic patients. Comparison disorders include complex partial epilepsy, psychotic depression and schizophrenia with comorbid alcoholism. Schizophrenia is conceived of as a brain disease, with its genesis a pathological event probably occurring some considerable time before the clinical onset of the disorder. The clinical manifestations of the disease are the result of pathological brain processes, of which the observable brain dysmorphology is a marker. In addition, dysfunction in motor, cognitive, and electrophysiological processes are probably related to the brain dysmorphology. The temporal course of the pathological processes, as well as factors such as aging, gender age of symptom onset and duration of illness since clinical onset, may influence the brain dysmorphology and contribute to the clinical, behavioral and biological heterogeneity of schizophrenia. The MHCRC consists of Administrative, Clinical and Biostatistical/Database Cores, plus five Scientific Cores (Structural Neuroimaging, Functional Neuroimaging, Experimental Neuropsychology, Waking Electrophysiology and Sleep Electrophysiology). Some studies performed by Core laboratories are designed to test whether the brain dysmoprphology and dysfunction are localized and focal or are widely distributed. Other studies are theoretically independent of questions about brain structure. New functional imaging studies will complement the structural studies and include positron emission tomography, magnetic resonance spectroscopic imaging, and functional magnetic resonance imaging. The Center has an inpatient diagnosis and treatment facility and an outpatient follow-up program. We have established a collaboration with a large stat hospital allowing us to study patients with more severe disease and earlier onset, and we have established collaborations with specialty clinics at Stanford University Medical Center for recruitment of patients with comparison diagnoses. The MHCRC also serves as a training site for medical students, residents and fellows.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH030854-20
Application #
2033575
Study Section
Neuroscience Subcommittee (MHSP)
Project Start
1977-09-29
Project End
1998-11-30
Budget Start
1997-07-10
Budget End
1998-11-30
Support Year
20
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Stanford University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Deshmukh, Anjali; Rosenbloom, Margaret J; De Rosa, Eve et al. (2005) Regional striatal volume abnormalities in schizophrenia: effects of comorbidity for alcoholism, recency of alcoholic drinking, and antipsychotic medication type. Schizophr Res 79:189-200
Sullivan, Edith V; Rosenbloom, Margaret J; Pfefferbaum, Adolf (2004) Balance and gait deficits in schizophrenia compounded by the comorbidity of alcoholism. Am J Psychiatry 161:751-5
Mathalon, Daniel H; Pfefferbaum, Adolf; Lim, Kelvin O et al. (2003) Compounded brain volume deficits in schizophrenia-alcoholism comorbidity. Arch Gen Psychiatry 60:245-52
Mathalon, Daniel H; Bennett, Amy; Askari, Nusha et al. (2003) Response-monitoring dysfunction in aging and Alzheimer's disease: an event-related potential study. Neurobiol Aging 24:675-85
Sullivan, Edith V; Rosenbloom, Margaret J; Serventi, Kathleen L et al. (2003) Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia. Am J Psychiatry 160:1110-6
Panizzon, Matthew S; Hoff, Anne L; Nordahl, Thomas E et al. (2003) Sex differences in the corpus callosum of patients with schizophrenia. Schizophr Res 62:115-22
Deshmukh, Anjali; Rosenbloom, Margaret J; Pfefferbaum, Adolf et al. (2002) Clinical signs of cerebellar dysfunction in schizophrenia, alcoholism, and their comorbidity. Schizophr Res 57:281-91
Pfefferbaum, Adolf; Rosenbloom, Margaret; Serventi, Kathleen L et al. (2002) Corpus callosum, pons, and cortical white matter in alcoholic women. Alcohol Clin Exp Res 26:400-6
Alpert, Murray; Shaw, Richard J; Pouget, Enrique R et al. (2002) A comparison of clinical ratings with vocal acoustic measures of flat affect and alogia. J Psychiatr Res 36:347-53
Mathalon, Daniel H; Fedor, Mark; Faustman, William O et al. (2002) Response-monitoring dysfunction in schizophrenia: an event-related brain potential study. J Abnorm Psychol 111:22-41

Showing the most recent 10 out of 231 publications